.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
US Army
McKinsey
Dow
Covington
Farmers Insurance
Healthtrust
Cantor Fitzgerald
Chinese Patent Office
Moodys

Generated: July 20, 2017

DrugPatentWatch Database Preview

ANTHELIOS SX Drug Profile

« Back to Dashboard

Which patents cover Anthelios Sx, and when can generic versions of Anthelios Sx launch?

Anthelios Sx is a drug marketed by Loreal Usa and is included in one NDA.

The generic ingredient in ANTHELIOS SX is avobenzone; ecamsule; octocrylene. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene profile page.

Summary for Tradename: ANTHELIOS SX

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list1
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ANTHELIOS SX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Loreal Usa
ANTHELIOS SX
avobenzone; ecamsule; octocrylene
CREAM;TOPICAL021502-001Jul 21, 2006OTCYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ANTHELIOS SX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Loreal Usa
ANTHELIOS SX
avobenzone; ecamsule; octocrylene
CREAM;TOPICAL021502-001Jul 21, 20064,585,597► Subscribe
Loreal Usa
ANTHELIOS SX
avobenzone; ecamsule; octocrylene
CREAM;TOPICAL021502-001Jul 21, 20065,587,150► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
McKinsey
Queensland Health
Farmers Insurance
Fish and Richardson
Medtronic
Novartis
Cantor Fitzgerald
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot